Upstream Manufacturing Webinars

  1. Comprehensive Bioprocess Control: Substrate, Metabolite And Product Analysis 5/6/2026

    Explore how multi-parameter bioprocess analyzers support monitoring of 30+ bioprocess parameters across mammalian and microbial systems to optimize yield and product quality.

  2. Aligning Upstream And Downstream Development (Part 2) 5/5/2026

    In Part 2 of this conversation on “Better Biopharma,” panelists from the Bioprocess Online Live event “Optimizing Process Development Through Upstream And Downstream Integration” continue their discussion about how upstream and downstream development teams can work together to accelerate timelines and reduce risk and bottlenecks in process development.

  3. From DNA To IND In As Little As 6 Months 4/27/2026

    Discover how an integrated, platform-driven CMC approach can accelerate your antibody program from DNA to IND in as little as six months while reducing risk and maintaining quality and regulatory alignment.

  4. Aligning Upstream And Downstream Development (Part 1) 4/20/2026

    In this episode of “Better Biopharma,” panelists from the Bioprocess Online Live event “Optimizing Process Development Through Upstream And Downstream Integration” continue their conversation about how upstream and downstream development teams can work together to accelerate timelines and reduce risks and bottlenecks in process development.

  5. Where Sourcing Meets Science: Smarter Collaboration, Better Outcomes 4/20/2026

    See how collaboration-driven raw material control reduces variability, improves cell culture performance, and delivers measurable cost and productivity gains in biotherapeutic manufacturing.

  6. Maximizing Performance And Quality In Fed-Batch And Perfusion-Based IgG Productions Customer Interview 4/16/2026

    From lab to production scale: a researcher's firsthand account of what bioreactor scaling and high-density perfusion really demand in practice.

  7. How MacroGenics Increased mAb Titers By Up To 80% In Scale-Up 4/16/2026

    Learn how a structured, scalable approach to process development can help improve productivity, maintain product quality, and support a smoother transition to manufacturing.

  8. Industrializing Cell Therapy With Perfusion 4/14/2026

    Explore how intensified perfusion strategies enable rapid, high‑density CAR‑T expansion, predictive scale‑down modeling, and efficient automated harvest, supporting shorter timelines and higher yields.

  9. Defined Media, Defined Results: Scaling E. coli From Bench To Fermenter 4/9/2026

    Understand the benefits of chemically defined media in E. coli systems, explore real-world plasmid DNA data, and learn practical strategies for scaling to robust manufacturing.

  10. Scalable Biologics Production Trends: Featuring Omar Wahab 4/9/2026

    Listen in as Dr. Corey Stanton speaks with Dr. Omar Wahab, Vice President of Bioprocessing at Lonza, about the strategic role of cell culture media in scalable biologics manufacturing.